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A b s t r a c t
:In the assessment of cardiovascular disease, the clinical significance of left atrial (LA) pressure-volume relations has largely 
been overlooked in contrast to left ventricular (LV) compliance. However, LA compliance has recently gained more attention. Net 
atrioventricular compliance (Cn), a joint measure of LA and LV compliance, can be calculated non-invasively by a previously validat-
ed method using parameters from standard echocardiography. Compliance measurement may be of relevance in selected clinical 
settings. First, subjects with low Cn are more likely to have their mitral valve area overestimated by the traditional mitral pressure 
half-time method. Consequently, low Cn in mitral stenosis, usually resulting from reduced LA compliance, can be mistaken for mild 
mitral stenosis. Second, low Cn independently predicted pulmonary hypertension and disease progression in medically treated 
mitral stenosis, and late cardiovascular complications after successful percutaneous mitral valvuloplasty. Decreased LA compliance 
also accounts for stiff LA syndrome, a rare complication of radiofrequency catheter ablation for atrial fibrillation, manifesting as 
otherwise unexplained heart failure with elevated LA pressure and pulmonary hypertension. Finally, depressed pre-ablation LA stiff-
ness index, i.e. the ratio of the change in LA pressure to the corresponding change in LA volume during passive LA filling, was an 
independent predictor of arrhythmia recurrence. Thus, LA stiffening translates into adverse clinical outcomes in patients with mitral 
stenosis or atrial fibrillation undergoing interventional procedures. Whether reduced LA compliance after LA appendage occlusion 
can result in the LA stiff syndrome, has not been reported so far.
Key words: mitral stenosis, radiofrequency catheter ablation, percutaneous mitral valvuloplasty, percutaneous left atrial ap-
pendage closure, left atrial compliance.
The concept of net atrioventricular 
compliance, a joint measure of left atrial 
and left ventricular compliance 
As early as 30 years ago, Thomas et al. [1] demon-
strated that in the setting of acute mitral valvotomy, 
mitral pressure half-time (T1/2) (the time required for the 
transmitral pressure gradient to fall to half of its maximal 
early diastolic value), traditionally perceived as an inverse 
measure of mitral valve area (MVA) [2], lost its predictive 
accuracy after percutaneous balloon mitral valvuloplasty 
(PBMV). In fact, the data showed essentially no correla-
tion between T
1/2 and MVA immediately after valvotomy. 
These findings strongly suggested that acute changes in 
other hemodynamic variables are likely to play a role in 
the breakdown of the traditional method for determining 
MVA from T1/2 directly after dilation of a stenotic mitral 
valve [1]. Therefore, they proposed estimation of the net 
atrioventricular compliance (Cn) in order to overcome 
this limitation. In brief, this concept was based on the 
following considerations with regard to early LV filling.
Both LV compliance (Cv) and LA compliance (Ca) are 
described by the classical equations: 
Cv = dV
v
/dp
v
 and Ca = dV
a
/dp
a
, 
where V and p represent volume and pressure, respec-
tively, in the LV (V
v
 and p
v
) and the LA (V
a
 and p
a
). 
Unfortunately, direct measurements of LA and LV 
pressures are extremely rare in clinical practice. However, 
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we can easily measure transmitral blood flow by Doppler 
echocardiography, thereby also estimating transmitral 
pressure gradient by the Bernoulli formula. Additionally, 
absolute values of changes in LA and LV volume during 
early LV filling can be assumed equal, if we neglect blood 
flow from pulmonary veins into the LA during early LV 
filling (dV
v
 = –dV
a
). 
According to Thomas et al. [1], net atrioventricular Cn 
is defined as the ratio of the rates of change in ventricu-
lar volume (V
v
) and transmitral pressure difference (Δp = 
p
a
 – p
v
) during early LV filling: 
Cn = –dV
v
/dΔp, 
with the negative sign arising because an increase in LV 
volume is associated with a decrease in transmitral pres-
sure gradient [3]. 
Notably, Cn is related to Cv and Ca as: 1/Cn = 1/Cv + 
1/Ca, in analogy to two capacitors connected in series, 
and Cn is lower than Ca and Cv.
On the basis of in vitro modeling of transmitral flow, 
Newton’s second law of motion and the continuity equa-
tion with some simplifying assumptions and the inte-
gration of several equations, Thomas et al. [1] derived 
a modified approximate formula linking effective MVA to 
mitral T
1/2
: 
T
1/2
 [ms] = 11.6 × Cn [ml/mm Hg] × (Δp
0
)1/2/MVA [cm2], 
where Cn represents net atrioventricular compliance and 
Δp
0
 [mm Hg] is the maximal transmitral pressure gradi-
ent during early LA filling. 
The simplifications, shown as allowable in the in 
vitro model, encompassed inclusion of the LA and pul-
monary veins in a common chamber, ignoring LV active 
relaxation, neglecting viscous mitral resistance with con-
sequent use of the simplified Bernoulli equation for the 
transmitral pressure gradient−flow velocity relationship, 
and constant Cn during early LV filling owing to opposite 
changes in LA and LV compliance [1].
The authors [1] also confirmed the superiority of this 
novel formula over the traditional equation (T
1/2 = 220/
MVA) [2], validating it in patients after mitral valvotomy, 
thereby emphasizing the importance of simultaneous 
changes in LA and LV compliance chamber compliance 
after valvotomy for the accuracy of MVA calculations 
from T
1/2. Keeping in mind the simplified relationship be-
tween transmitral pressure gradient (Δp) and flow veloci-
ty (v), the formula can be transformed into another form, 
as demonstrated by Flachskampf et al. [3]: 
Cn [ml/mm Hg] = –1270 × MVA [cm2]/dv/dt.
Consequently, because dv/dt may be approximated by 
the deceleration rate of the early transmitral flow ve-
locity profile (E-wave), the formula can finally be re-ex-
pressed [4] as:
Cn [ml/mm Hg] = 1270 × MVA [cm2]/ 
E-wave downslope [cm/s2].
Importantly, effective MVA can be estimated either 
by the continuity equation [3] or planimetry [5], both of 
which may be used based on standard echocardiography 
in real-world patients. 
As mentioned before, Cn is influenced by both Ca 
and Cv. This can result from either LV or LA stiffening (or 
both), i.e. with the LV or LA operating on their respective 
steeper pressure-volume curves. Accordingly, LV stiffen-
ing would lead to a more rapid increase in LV pressure 
during early LV filling, while LA stiffening would acceler-
ate a simultaneous fall in LA pressure. Both these effects 
would translate into a  decreasing transmitral pressure 
gradient, a  driving force of LV filling, thereby reducing 
peak transmitral velocity during the early LV filling phase. 
These effects would predominate if changes in Ca or Cv 
did not trigger activation of compensatory mechanisms 
aimed at the preservation of LV filling volume and stroke 
volume. However, Thomas et al. [6] showed, by means 
of their complex mathematical model of LV filling, that 
if we allow LA pressure to change in order to keep the 
LV filling volume constant, lower LA or LV compliance re-
sults in increased, not decreased, E-wave peaks, and an 
elevated E-wave deceleration rate. This is equivalent to 
a more restrictive profile of early LV filling, commonly ob-
served in patients with impaired LV compliance and ex-
plained by higher LA pressure to maintain LV stroke vol-
ume. Additionally, an increased E-wave deceleration rate 
corresponds to lower Cn, calculated as MVA divided by 
the E-wave slope. Therefore, the mathematical models of 
early LV filling [1, 6], despite their inherent assumptions, 
simplifications and limitations, provide a good descrip-
tion of phenomena observed in clinical practice. 
Low net atrioventricular compliance – 
a predictor of pulmonary hypertension, 
exercise intolerance and disease 
progression in mitral stenosis on medical 
therapy
As a  practical clinical application of the above-pre-
sented method of Cn assessment, Schwammenthal et al. 
[4] demonstrated that low Cn, but not MVA, predicted 
not only resting systolic pulmonary artery pressure (PAP), 
but especially the magnitude of its exercise-induced ris-
es in patients with moderate or severe mitral stenosis. 
In addition, subjects with low Cn (≤ 4 ml/mm Hg, lower 
tertile) were more symptomatic and, importantly, much 
more likely to have their MVA overestimated by the T1/2 
method compared to MVA computed from the continuity 
equation or planimetry. Consequently, low Cn, usually re-
sulting from low LA compliance, the main determinant of 
Cn in clinically relevant mitral stenosis, can be mistaken 
for mild mitral stenosis and these patients may be de-
prived of potential benefits of mitral valvotomy owing to 
a false diagnosis of non-severe mitral stenosis [4].
Pulmonary hypertension is recognized as a  clas-
sical tool to assess the severity of disease in patients 
with mitral stenosis. Curiously, systolic PAP at rest varies 
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among patients presenting with similar levels of mitral 
obstruction, which highlights the importance of non-val-
vular factors for hemodynamic consequences of mitral 
stenosis. Interestingly, Li et al. [7] found that low Cn was 
a major independent predictor of LA pressure and systol-
ic PAP measured by cardiac catheterization in patients 
with severe pure mitral stenosis. 
More recently, Nunes et al. [8] studied 140 patients 
with rheumatic mild-to-severe mitral stenosis (mean 
MVA: 1.2 ±0.4 cm2), excluding all subjects with factors 
that could have potentially otherwise influenced pulmo-
nary pressure. Low Cn, high mean transvalvular gradient, 
and small MVA were the only factors influencing systolic 
PAP in multivariate regression irrespective of their mu-
tual relations. Additionally, polling all the study subjects 
together, only 18% of the patients with a Cn level above 
a cut-off > 4 ml/mm Hg were referred for an interventional 
therapy (percutaneous or operative), while in those with 
a Cn below or equal to this cut-off value, the respective 
proportion was as high as 82% over a median follow-up 
of 22 months. However, from the clinical point of view, 
perhaps an even more relevant feature of Cn could be an 
ability to predict clinical outcome in a subset of the mitral 
stenosis patients who presented asymptomatically [8]. 
In 52 initially asymptomatic patients with moderate or 
severe mitral stenosis, mitral stenosis-related interven-
tions were performed in 30% and 69% of the former (i.e. 
Cn > 4 ml/mm Hg) and the latter (i.e. Cn ≤ 4 ml/mm Hg) 
subgroup, respectively, based on a  complex clinical as-
sessment encompassing functional status, mitral orifice 
obstruction severity and PAP, in agreement with practice 
guidelines. Notably, this association between low Cn and 
a clinical need for interventional therapy retained its ad-
ditional and incremental predictive effect in addition to 
classical indices of mitral stenosis, including valve area, 
transmitral pressure gradient and PAP [8]. 
Jung et al. [9] demonstrated that also Cn changes in 
response to exercise may be clinically relevant. Patients 
with asymptomatic moderate rheumatic mitral stenosis 
(MVA: 1.0–1.5 cm2) who developed clinically relevant 
dyspnea during symptom-limited exercise echocardiog-
raphy exhibited significantly greater early-exercise in-
duced decreases in Cn at a workload of 50 W than those 
who did not present exertional dyspnea, averaging 70% 
vs. 50% for relative Cn reductions, respectively. Moreover, 
although Cn and systolic PAP were inversely related both 
at rest and during peak exercise, the relative Cn decrease 
at 50 W, but not MVA, was the only independent deter-
minant of exercise intolerance after adjustment for sys-
tolic PAP at peak exercise and its relative increases at 
50 W  [9]. Thus, these findings may aid physicians in 
furthering their understanding of the pathophysiolo-
gy behind mitral stenosis, with a  focus beyond obvi-
ous valve-related factors. As decreased LA compliance 
corresponds to a  more pronounced rise in LA pressure 
for a  given increment in LA volume, this is likely to be 
a  mechanistic basis of the contribution of the proper-
ties of the LA wall to the development of complications 
surrounding mitral stenosis. Additionally, Cn can provide 
prognostic value for patients with mitral stenosis and 
may additionally help in monitoring and assessing the 
risk in asymptomatic patients with early-stage disease.
Low net atrioventricular compliance 
– a predictor of late cardiovascular 
complications in mitral stenosis after 
successful percutaneous balloon 
valvuloplasty
In 150 patients with symptomatic moderate or se-
vere mitral stenosis, Mahfouz et al. [10] demonstrated 
that low baseline Cn (≤ 3.75 ml/mm Hg) was associated 
with higher transmitral pressure gradient, mean LA pres-
sure and systolic PAP assessed after, but not before, suc-
cessful PBMV. Additionally, upon conducting a follow-up 
over a median of 32 months, they found that patients 
with baseline (i.e. pre-procedural) Cn ≤ 3.75 ml/mm Hg 
had a higher incidence of a composite adverse outcome, 
including cardiovascular death, hospitalization for de-
compensated heart failure, mitral valve reintervention, 
systolic PAP re-elevation, newly developed atrial fibrilla-
tion and worsening of right ventricular function. These 
findings can be attributed to the fact that, inasmuch as 
LA compliance contributes to Cn, low Cn appears to re-
flect fibrosis and stiffening of the LA wall, probably owing 
to a chronic rheumatic process affecting the LA myocar-
dium [10]. So, patients with a lower Cn are likely to have 
persistently worsened LA function, in turn increasing the 
risk of late adverse outcomes despite successful PBMV. 
Additionally, Nunes et al. [11] showed that low Cn was 
an independent predictor of both cardiovascular death 
and all-cause mortality combined with mitral valve re-
interventions in 427 patients following PBMV for severe 
mitral stenosis followed for a median of 31 months. They 
also demonstrated that pre-PBMV Cn ≤ 4 ml/mm Hg, 
when incorporated into a  5-year mortality risk predic-
tion model, significantly improved its ability to identify 
patients at risk of late cardiovascular death. This may be 
related not only to persistent dysfunction of the LA by 
itself, when the LA operates on a steeper portion of its 
pressure-volume curve with consequent backward trans-
mission of elevated LA pressure, as suggested previously 
[10]. Low Cn can also coexist with long-lasting changes 
of the pulmonary vasculature, which often does not re-
verse despite a successful valvuloplasty, resulting in the 
continued elevation of pulmonary vascular resistance in 
the years following the procedure [11]. These irreversible 
changes may include not only pulmonary arteries, but 
also veins exposed to chronically elevated pressure. In 
fact, the concept of Cn was based on a model of early 
LV filling, where LA and pulmonary veins are assumed to 
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be a  common elastic chamber receiving all the cardiac 
stroke volume during systole and discharging it passively 
through the mitral valve into the LV in diastole [1]. Thus, 
this assumption implies that elastic properties of pulmo-
nary veins also affect Cn. 
Accordingly, Cn measurement, in addition to conven-
tional clinical and echocardiographic characteristics, can 
provide a better insight into potential benefits of PBMV 
on an individual basis in patients referred for this pro-
cedure. Hence, physicians can more accurately identify 
those who are at higher risk of developing late adverse 
cardiovascular outcomes despite successful PBMV. 
Stiff left atrial syndrome – a rare 
complication of radiofrequency catheter 
ablation for atrial fibrillation
Atrial fibrillation has been linked to atrial enlarge-
ment, having a  close correlation with electrical and 
structural remodeling of both atria. Interestingly, reduc-
tions in both LA and right atrial volume were observed 
in patients 6–12 months after radiofrequency catheter 
ablation (RFCA) [12, 13]. Moreover, this effect was inde-
pendent of whether AF recurred during the follow-up 
[12, 13]. Notably, Choi et al. [14], comparing patients 
who had maintained sinus rhythm 3 months after either 
RFCA or electrical cardioversion, reported more signifi-
cant decreases in LA volume in the former than in the 
latter subgroup. Furthermore, Witt el al. [15] estimated 
that about 8% of patients undergoing RFCA exhibit-
ed rises in right ventricular systolic pressure exceeding 
10 mm Hg 3 months after ablation compared to pre-ab-
lation values, and ascribed it to reduced LA compliance 
with consequent otherwise unexplained pulmonary hy-
pertension, a basis of LA stiff syndrome. In their experi-
ence [15], the RFCA-induced increase in right ventricular 
systolic pressure was associated with a more restrictive 
profile of post-ablation, but not pre-ablation, LV filling, 
a  likely consequence of elevated LA pressure, thereby 
mimicking more pronounced LV diastolic dysfunction. In 
a study aimed at explaining these changes, Hof et al. [16] 
performed a  magnetic resonance imaging (MRI) study 
of 206 patients who received pulmonary vein isolation 
during RFCA. The report showed post-ablation LA fibrosis 
in as many as 77% of a  subgroup of 52 subjects who 
underwent late enhancement MRI, despite absent fibro-
sis in the regions of interest prior to RFCA. In addition, 
maximal LA volume decreased irrespective of fibrillation 
recurrence, which suggests a close relationship between 
LA fibrosis and reduced LA volume after RFCA [16]. 
The concept of the stiff LA syndrome was first pro-
posed by Pilote et al. [17], who described a 67-year-old 
woman presenting 7 years after mitral valve replacement 
with pulmonary edema and severe right ventricular heart 
failure despite no prosthetic valve dysfunction, coupled 
with pulmonary hypertension and large V-waves on 
pulmonary capillary wedge pressure tracing, and calcifi-
cation lesions in the LA wall on autopsy. In a large pro-
spective study of 1380 consecutive patients referred for 
RFCA, Gibson et al. [18] described the stiff LA syndrome 
in 19 (1.4%) subjects, and identified severe pre-operative 
LA scarring (defined as an absence of voltage on bipolar 
LA electrograms and validated by electroanatomic map-
ping), diabetes and obstructive sleep apnea as its inde-
pendent predictors. That lower pre-procedural LA size 
and higher mean LA pressure were also independently 
related to future occurrence of the syndrome might have 
indirectly suggested decreased compliance of the LA op-
erating on a steeper pressure-volume curve [18].
Accordingly, the stiff LA syndrome, a rare complication 
of RFCA or cardiac surgery, is now recognized as new-on-
set dyspnea in the absence of significant LV dysfunction, 
constrictive pericarditis, worse than mild mitral valve 
disease or pulmonary vein stenosis – accompanied by 
pulmonary hypertension, elevated mean LA pressure and 
large V-waves ≥ 10 mm Hg above the mean LA pressure 
(or > 7 mm Hg above the mean pulmonary wedge pres-
sure) on invasive pressure tracings [18–20]. The above 
presented clinical constellation is ascribed to reduced LA 
compliance, which accounts for an intriguing discrepancy 
between increased LA pressure and normal LV end-di-
astolic pressure despite an absence of mitral stenosis 
[18–20]. It has also been suggested that both multiple 
ablation procedures and modern extensive LA ablation 
techniques beyond pulmonary vein isolation may lead to 
more pronounced scarring of the LA wall [19, 20]. Accord-
ingly, the stiff LA syndrome might be increasingly recog-
nized in the future as an underlying cause of otherwise 
unexplained heart failure with elevated LA pressure and 
pulmonary hypertension after RFCA. 
Notably, another recognized technique of ablation for 
atrial fibrillation, cryoballoon ablation, not only exhibited 
efficacy similar to RFCA [21], but also induced a compa-
rable extent of LA fibrosis at 3 months after initial pulmo-
nary vein isolation [22]. This observation [22] supports 
the notion that both RFCA and cryoballoon ablation are 
likely to have potential to evoke LA scarring and predis-
pose to the stiff LA syndrome. 
Interestingly, a novel interventional strategy aimed at 
LA and LV depressurization in advanced diastolic heart 
failure by creating a  controlled atrial septal defect [23] 
(“neo-ASD”) was recently applied, for the first time, to 
a  patient with the stiff LA syndrome after 3 ablation 
procedures within the preceding 9 years, presenting as 
severe dyspnea and signs of right-sided congestion, re-
fractory to diuretics [24]. This approach resulted in a sig-
nificant clinical improvement [24], which was discussed 
by Maeder et al. [25], who argued that a  persistent 
post-puncture atrial septal defect was a  likely explana-
tion of only minor symptoms in their patient with the 
LA stiff syndrome after multiple ablations, in spite of 
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a mean pulmonary wedge pressure of 24 mm Hg with 
large V-waves of 40 mm Hg.
Pre-procedural left atrial stiffness – 
a predictor of arrhythmia recurrence after 
catheter ablation for atrial fibrillation
As discussed above, development of excessive LA 
stiffening in response to RFCA may translate into clin-
ical manifestations of heart failure termed the stiff LA 
syndrome. However, pre-ablation LA stiffness may also 
be of relevance, predisposing to the recurrence of atrial 
fibrillation. Identification of patients at risk of arrhyth-
mia recurrence still poses a challenge. In a study of 700 
consecutive patients followed for a mean of 16 months 
after a first pulmonary vein isolation procedure, Verma 
et al. [26] reported extensive pre-procedural LA scarring 
(by contact voltage mapping) as the only independent 
predictor of arrhythmia recurrence. By means of delayed 
enhancement MRI, Marrouche et al. [27] demonstrated 
that the extent of pre-procedural LA fibrosis was asso-
ciated with a higher likelihood of atrial fibrillation recur-
rence in 272 participants of a multicenter study
More recently, Khurram et al. [28] investigated the as-
sociations between LA pressure-volume relations and the 
recurrence of atrial fibrillation in 160 patients who un-
derwent RFCA for the first time. The LA pressure-volume 
diagram consists of 2 loops arranged in a figure-of-eight 
pattern [28, 29] (Figure 1 A). The LA stiffness index was 
derived from the LA atrial pressure-volume curve as the 
ratio of change in LA pressure to the change in LA volume 
during passive LA filling at the time of RFCA [28] (Figure 
1 B). The authors were able to show that an increased 
value of the pre-ablation LA stiffness index was the only 
independent predictor of recurrence of atrial fibrillation 
over a mean follow-up of 10 months [28].
This observation is in accordance with a  previous 
study by Park et al. [30], who reported higher pre-abla-
tion maximal LA pressure in 454 patients undergoing 
RFCA who exhibited the recurrence of atrial fibrillation. 
Importantly, higher maximal LA pressure was accompa-
nied by higher LA volume, decreased LA appendage emp-
tying velocity and low intracardiac LA electrogram volt-
age, termed “electroanatomical remodeling of the LA” 
[30]. Finally, these observations were later confirmed in 
334 patients with a structurally and functionally normal 
heart, in whom pre-ablation LA pulse pressure (measured 
in sinus rhythm as the difference in LA pressure between 
the nadir of the X-wave and the peak of the V-wave – 
a surrogate approximate index of depressed LA compli-
ance) was associated with lower LA electrogram voltage 
and independently predicted atrial fibrillation recurrence 
during a mean follow-up of 17 months [31].
Hence, though there are well-recognized factors con-
tributing to atrial fibrillation, such as mitral stenosis, LV 
dysfunction, coronary artery disease (CAD), hyperten-
sion, obesity and aging, the above observations further 
potentiated the idea that fibrosis in the LA wall can be 
a crucial link between development of “atrial myopathy” 
(an anatomical substrate for the onset/persistence of 
atrial fibrillation) and predisposing conditions, including 
atrial overload and stretch, inflammation and oxidative 
stress [32]. Therefore, LA abnormalities detected by var-
ious diagnostic techniques – echocardiography (includ-
ing novel techniques, e.g. speckle-tracking), MRI, cardiac 
Figure 1. A – Graphical representation of a typical left atrium (LA) pressure–volume loop. Point C is the closure 
of mitral valve in cardiac systole, and point O is opening of mitral valve at the start of ventricular diastole show-
ing the 4 phases of the LA cardiac cycle. B – Measurement of LA stiffness index (ΔP/ΔV). The slope of phase 
2 defines the LA stiffness. The LA stiffness index approximates the slope of phase 2 by taking the ratio of the 
change in pressure to the change in volume (ΔP/ΔV) that occurs during the passive filling phase. Here, phase 
2 of the 2 patients are highlighted with red color line where solid red line of a compliant LA can be compared 
with a stiff LA with higher LA pressure (ΔP) and smaller corresponding change in volume (ΔV). Reproduced from 
Ref. No. 28 with permission of Wolters Kluwer Health, Inc. (license # 4322140443904)
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catheterization and intracardiac LA electrogram voltage 
– are likely to reflect different aspects of LA myopathy, 
encompassing depressed LA systolic and diastolic func-
tion, LA scarring/fibrosis and electrical remodeling. These 
mechanisms seem to be a plausible explanation for the 
association of depressed pre-ablation LA compliance 
with arrhythmia recurrence after RFCA. 
Radiofrequency catheter ablation, especially when 
extensive or repeated, may further potentiate LA fibrosis 
[18, 19]. Importantly, poor post-procedural scar formation 
in the ablated area was associated with the recurrence 
of atrial fibrillation [33, 34]. Intriguingly, these findings 
apparently contrast with a well-recognized positive rela-
tionship between the extent of pre-ablation LA fibrosis 
and recurrent arrhythmia [27, 35]. Therefore, after RFCA, 
beneficial “anti-arrhythmic” effects of complete isolation 
and elimination of the triggers of atrial fibrillation with 
consequent extensive post-procedural LA scarring can 
predominate, thereby counteracting the association of 
pre-procedural LA fibrosis with arrhythmia recurrence. 
However, with regard to LA hemodynamics, patients with 
lower pre-ablation LA compliance might also be predis-
posed to RFCA-induced LA stiffening, manifesting as the 
stiff LA syndrome. That the stiff LA syndrome develops 
especially after multiple ablation procedures [18–20], 
supports this concept. Thus, extensive post-ablation LA 
scarring appears to be linked to the efficacy of arrhyth-
mia prevention, yet poses a risk of the stiff LA syndrome 
and symptoms of pulmonary congestion in selected pa-
tients. Future research can be aimed at optimizing abla-
tion techniques to achieve the best anti-arrhythmic ef-
fect at the lowest possible cost for LA compliance.
Reduced left atrial compliance after left 
atrial appendage closure
Percutaneous LA appendage (LAA) occlusion has been 
increasingly utilized for stroke prevention in patients 
with atrial fibrillation and contraindications to long-term 
anticoagulation [36]. With the increasing number of in-
terventional LAA occlusion procedures, two questions 
arise: How does LAA occlusion affect LA compliance? And 
how do these changes, if present, translate into clinical 
consequences? Early observations in isolated canine 
hearts [37] and open-chest dogs [38] revealed that the 
LA pressure-volume curve was shifted upward and to 
the left after the exclusion [37] or removal [38] of the 
LAA, consistent with reduced LA compliance. These re-
sults were later confirmed by Tabata et al. [39] in 15 pa- 
tients undergoing LA clamping during cardiac surgery, 
who also exhibited significant rises in mean LA pressure 
and maximal LA dimension. Additionally, changes in pul-
monary venous and transmitral flow reflected elevated 
LA pressure, with lower peak second systolic pulmonary 
flow velocity and accelerated early diastolic mitral flow, 
owing to an excessive rise in LA pressure prior to mitral 
valve opening. Importantly, similar changes, i.e. elevated 
mean LA pressure and maximal LA volume, were recent-
ly reported in 58 consecutive patients after successful 
LAA occlusion [40]. The authors linked these effects to 
probable reductions in LA compliance with consequent 
increases in LA pressure after the procedure [40]. Finally, 
the same mechanism was proposed as an explanation 
of almost 4-fold higher risk of early postoperative atrial 
fibrillation in 10,633 subjects who underwent prophylac-
tic surgical exclusion of the LAA during cardiac surgery 
[41]. The latter report represents a brilliant example of 
how an early experimental observation by Davis et al. 
[37], i.e. 2.6 times higher compliance of the LAA com-
pared to the remaining LA chamber, can be helpful to 
understand the basis of symptoms in real-world patients 
almost 30 years later [41]. 
In summary, both RFCA and LAA closure are likely 
to induce reductions in LA compliance, which seems an 
inevitable consequence of these procedures. More im-
portantly, the incidence of its symptomatic presentation 
– post-ablation stiff LA syndrome – is rare, and the syn-
drome has not yet been described after LAA closure. Nev-
ertheless, keeping in mind the growing number of LAA 
occlusion devices, it does not seem implausible that such 
a case may emerge in the future. Admittedly, Clare et al. 
[42] observed the stiff LA syndrome in a patient after sur-
gical epicardial radiofrequency pulmonary vein isolation 
and LAA resection, followed by re-isolation of pulmonary 
veins by endocardial RFCA 5 years later. However, the 
combination of various procedures made it impossible to 
identify the main contributor to LA scarring. 
Hence, irrespective of the type of LA-related interven-
tions, RFCA or LAA closure, proper preoperative identification 
of patients at risk for clinical manifestations of post-proce-
dural LA stiffening should be a focus of further research.
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